Department of Nephrology, Dialysis and Transplantation, Amiens Medical Center, Amiens 80054, France.
MP3CV Laboratory, UR UPJV 7517, University of Picardy Jules Verne, Amiens 80054, France.
Toxins (Basel). 2022 May 11;14(5):336. doi: 10.3390/toxins14050336.
Acute kidney injury (AKI) is a frequent disease encountered in the hospital, with a higher incidence in intensive care units. Despite progress in renal replacement therapy, AKI is still associated with early and late complications, especially cardiovascular events and mortality. The role of gut-derived protein-bound uremic toxins (PBUTs) in vascular and cardiac dysfunction has been extensively studied during chronic kidney disease (CKD), in particular, that of indoxyl sulfate (IS), para-cresyl sulfate (PCS), and indole-3-acetic acid (IAA), resulting in both experimental and clinical evidence. PBUTs, which accumulate when the excretory function of the kidneys is impaired, have a deleterious effect on and cause damage to cardiovascular tissues. However, the link between PBUTs and the cardiovascular complications of AKI and the pathophysiological mechanisms potentially involved are unclear. This review aims to summarize available data concerning the participation of PBUTs in the early and late cardiovascular complications of AKI.
急性肾损伤(AKI)是医院中常见的疾病,在重症监护病房中的发病率更高。尽管肾脏替代疗法取得了进展,但 AKI 仍与早期和晚期并发症相关,尤其是心血管事件和死亡率。在慢性肾脏病(CKD)期间,肠道来源的蛋白结合尿毒症毒素(PBUTs)在血管和心脏功能障碍中的作用已得到广泛研究,特别是硫酸吲哚酚(IS)、对甲酚硫酸(PCS)和吲哚-3-乙酸(IAA),这导致了实验和临床证据。当肾脏的排泄功能受损时,PBUTs 会积聚,对心血管组织造成有害影响并导致损伤。然而,PBUTs 与 AKI 的心血管并发症之间的联系以及潜在涉及的病理生理机制尚不清楚。本综述旨在总结有关 PBUTs 参与 AKI 的早期和晚期心血管并发症的现有数据。